인쇄하기
취소

Cold remedy makers publicizing safety of non-PPA substances

Published: 2004-08-12 07:00:00
Updated: 2004-08-12 07:00:00
With growing public anger over the belated response of the Korea Food and Drug Administration to prohibit 167 cold remedies containing phenylpropanolamine (PPA), a number of pharmaceutical firms are making desperate efforts to publicize the fact that their non-PPA cold remedies are safe and effective.

Market sources said that the majority of cold drug makers are extremely concerned about the...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.